Advertisement

Topics

CBSET Company Profile

07:25 EST 15th December 2018 | BioPortfolio

CBSET — Concord Biomedical Sciences & Emerging Technologies — is the preclinical research leader in critically important therapeutic fields such as interventional cardiology, renal disease and dialysis, chronic drug-resistant hypertension, women’s health, minimally invasive surgery, orthopedics, biological and synthetic tissue repair, drug delivery, bioresorbable devices, and combination medical device and drug-eluting products. The company was co-founded in 2006 by Peter Markham, Elazer Edelman, M.D., Ph.D., and Adam Groothuis, Ph.D. CBSET occupies a 35,000-square-foot, state-of-the-art facility near Boston that includes a vivarium, catheterization/imaging labs, surgical suites, dedicated labs for SEM, histopathology/pathology, and drug metabolism and pharmacokinetics. CBSET offers the latest equipment for fluoroscopy, echocardiography (TEE/TTE), electrophysiology, IVUS, optical coherence tomography (OCT), endoscopy/laparoscopy, surgical video recording, histology, microradiography, and SEM (Scanning Electron Microscopy). CBSET’s professional staff of 55 FTEs includes Ph.D.s, D.V.M.s and recognized experts in device and drug safety, surgery, imaging, specialized histopathology and pathology, veterinary medicine, pharmacology, lead optimization, pharmacokinetics and drug metabolism, and regulatory consulting. These individuals provide the basis for successful scientific collaborations, rapid concept advancements, unparalleled consulting services, and expert dissemination of information and findings to regulatory and scientific bodies.


News Articles [3 Associated News Articles listed on BioPortfolio]

Preclinical Safety Studies Demonstrate That Drug Presence Can Accentuate Pathological Responses at Stent Fracture Sites

“These findings could potentially have a seminal effect on development of innovative DES coating designs to treat coronary artery disease,” said Rami Tzafriri, Ph.D., Director...

CBSET Partner CILcare Leads Phase 2 of $2.1 Million Total Detect Project to Develop a Preclinical Model for Tinnitus Drug Therapy Development

CBSET partner CILcare, a world-leading CRO (

Preclinical studies show differences in healing responses to fractured and intact stent implanted in healthy, disease models

CBSET, a non-for-profit preclinical research institute dedicated to biomedical research, education and advancement of medical technologies, announced today that its scientists have published data and ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

CBSET Inc.

CBSET Inc., 500 Shire Way, Lexington, MA 02421 — is the preclinical research leader in critically important therapeutic fields such as interventional cardiology, renal diseas...

CBSET

CBSET — Concord Biomedical Sciences & Emerging Technologies — is the preclinical research leader in critically important therapeutic fields such as interventional cardio...

More Information about "CBSET" on BioPortfolio

We have published hundreds of CBSET news stories on BioPortfolio along with dozens of CBSET Clinical Trials and PubMed Articles about CBSET for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CBSET Companies in our database. You can also find out about relevant CBSET Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Dialysis
In medicine, dialysis is a process for removing waste and excess water from the blood, and is primarily used to provide an artificial replacement for lost kidney function in people with renal failure. Dialysis may be used for those with an acute disturba...


Corporate Database Quicklinks



Searches Linking to this Company Record